A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma

Clinical trial NCT00265135 · COMPLETED

Trial details

NCT number: NCT00265135
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2003-08-01
Primary completion: 2006-02-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.